These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38498071)

  • 1. Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Lebrón-Galán R; González-Mayorga A; Palomares FJ; Serrano MC; Clemente D
    Nanoscale; 2024 Apr; 16(15):7515-7531. PubMed ID: 38498071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
    Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Calahorra L; Cabañas-Cotillas M; Otaegui D; Castillo-Triviño T; Villar LM; Costa-Frossard L; Comabella M; Midaglia L; García-Domínguez JM; García-Arocha J; Ortega MC; Clemente D
    J Neuroinflammation; 2022 Nov; 19(1):277. PubMed ID: 36403026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
    Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D
    Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
    Jiang Q; Duan J; Van Kaer L; Yang G
    Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
    Melero-Jerez C; Alonso-Gómez A; Moñivas E; Lebrón-Galán R; Machín-Díaz I; de Castro F; Clemente D
    Neurobiol Dis; 2020 Jul; 140():104869. PubMed ID: 32278882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation.
    Melero-Jerez C; Fernández-Gómez B; Lebrón-Galán R; Ortega MC; Sánchez-de Lara I; Ojalvo AC; Clemente D; de Castro F
    Glia; 2021 Apr; 69(4):905-924. PubMed ID: 33217041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
    Ortega MC; Lebrón-Galán R; Machín-Díaz I; Naughton M; Pérez-Molina I; García-Arocha J; Garcia-Dominguez JM; Goicoechea-Briceño H; Vila-Del Sol V; Quintanero-Casero V; García-Montero R; Galán V; Calahorra L; Camacho-Toledano C; Martínez-Ginés ML; Fitzgerald DC; Clemente D
    Acta Neuropathol; 2023 Aug; 146(2):263-282. PubMed ID: 37243699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis.
    Radojević D; Bekić M; Gruden-Movsesijan A; Ilić N; Dinić M; Bisenić A; Golić N; Vučević D; Đokić J; Tomić S
    Gut Microbes; 2022; 14(1):2127455. PubMed ID: 36184742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
    Glenn JD; Liu C; Whartenby KA
    J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosis.
    Ghorbani MM; Farazmandfar T; Abediankenari S; Hassannia H; Maleki Z; Shahbazi M
    Immunotherapy; 2022 Jul; 14(10):789-798. PubMed ID: 35678041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H; Guo C; Yu X; Zuo D; Wang XY
    J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
    Casacuberta-Serra S; Costa C; Eixarch H; Mansilla MJ; López-Estévez S; Martorell L; Parés M; Montalban X; Espejo C; Barquinero J
    Exp Neurol; 2016 Dec; 286():50-60. PubMed ID: 27693617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.
    Zhang G; Zhu X; Yang F; Li J; Leng X; Mo C; Li L; Wang Y
    Pharm Biol; 2022 Dec; 60(1):899-908. PubMed ID: 36082828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
    Wegner A; Verhagen J; Wraith DC
    Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
    Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
    Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM; Esmon NL; Esmon CT; Bynoe MS
    J Immunol; 2013 Oct; 191(7):3764-77. PubMed ID: 23997223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.